These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22928120)

  • 1. The stemness phenotype model.
    Cruz MH; Sidén A; Calaf GM; Delwar ZM; Yakisich JS
    ISRN Oncol; 2012; 2012():392647. PubMed ID: 22928120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative models of cancer stem cells: The stemness phenotype model, 10 years later.
    Kaushik V; Kulkarni Y; Felix K; Azad N; Iyer AKV; Yakisich JS
    World J Stem Cells; 2021 Jul; 13(7):934-943. PubMed ID: 34367485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting hypoxia-induced tumor stemness by activating pathogen-induced stem cell niche defense.
    Bhuyan S; Pal B; Pathak L; Saikia PJ; Mitra S; Gayan S; Mokhtari RB; Li H; Ramana CV; Baishya D; Das B
    Front Immunol; 2022; 13():933329. PubMed ID: 36248858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stemness in Cancer: Stem Cells, Cancer Stem Cells, and Their Microenvironment.
    Aponte PM; Caicedo A
    Stem Cells Int; 2017; 2017():5619472. PubMed ID: 28473858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Formation, Stemness and Therapeutic Resistance of Cancer Stem Cells.
    Jing N; Gao WQ; Fang YX
    Front Cell Dev Biol; 2021; 9():641498. PubMed ID: 33898430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stemness and plasticity of lung cancer cells: paving the road for better therapy.
    Luo J; Zhou X; Yakisich JS
    Onco Targets Ther; 2014; 7():1129-34. PubMed ID: 25018639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identify multiple myeloma stem cells: Utopia?
    Saltarella I; Lamanuzzi A; Reale A; Vacca A; Ria R
    World J Stem Cells; 2015 Jan; 7(1):84-95. PubMed ID: 25621108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cells: perspectives for therapeutic targeting.
    Maccalli C; De Maria R
    Cancer Immunol Immunother; 2015 Jan; 64(1):91-7. PubMed ID: 25104304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hallmarks of the cancer cell of origin: Comparisons with "energetic" cancer stem cells (e-CSCs).
    Sotgia F; Fiorillo M; Lisanti MP
    Aging (Albany NY); 2019 Feb; 11(3):1065-1068. PubMed ID: 30760648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
    Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
    J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovatodiolide suppresses yes-associated protein 1-modulated cancer stem cell phenotypes in highly malignant hepatocellular carcinoma and sensitizes cancer cells to chemotherapy in vitro.
    Chang HL; Chen HA; Bamodu OA; Lee KF; Tzeng YM; Lee WH; Tsai JT
    Toxicol In Vitro; 2018 Sep; 51():74-82. PubMed ID: 29698666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
    Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
    J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpretation of interlocking key issues of cancer stem cells in malignant solid tumors.
    Liu WH; You N; Zhang N; Yan HT; Wang T; Huang Z; Liu HB; Tang LJ
    Cell Oncol (Dordr); 2012 Dec; 35(6):397-409. PubMed ID: 23179790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human endogenous retroviruses role in cancer cell stemness.
    Matteucci C; Balestrieri E; Argaw-Denboba A; Sinibaldi-Vallebona P
    Semin Cancer Biol; 2018 Dec; 53():17-30. PubMed ID: 30317035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
    Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
    Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YB-1 interplays with ERα to regulate the stemness and differentiation of ER-positive breast cancer stem cells.
    Yang F; Chen S; He S; Huo Q; Hu Y; Xie N
    Theranostics; 2020; 10(8):3816-3832. PubMed ID: 32206124
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeting the Interplay Between Cancer Fibroblasts, Mesenchymal Stem Cells, and Cancer Stem Cells in Desmoplastic Cancers.
    Chan TS; Shaked Y; Tsai KK
    Front Oncol; 2019; 9():688. PubMed ID: 31417869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
    Yadav AK; Desai NS
    Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
    Dahlrot RH
    Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
    Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
    Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.